PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Olanzapine ×

UPDATED
Regulatorische Updates
18. Sept. 2026•1 Min. Lesezeit
FDA Approves Teva Olanzapine/Fluoxetine Combination (ANDA077528)
FDA has approved Teva Pharmaceuticals' ANDA077528 for an oral capsule combining olanzapine and fluoxetine, with several dosage strengths, as of Feb 26 2021.
UPDATED
Regulatorische Updates
12. Sept. 2026•1 Min. Lesezeit
FDA Approves Teva Generic Olanzapine (ANDA 077243)
The FDA has approved Teva Pharmaceuticals’ generic olanzapine oral tablets (5‑20 mg) under ANDA 077243, with several labeling supplements filed since 2014.